Clinical Trial Update: Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing ferric carboxymaltose to placebo in patients with acute heart failure and iron deficiency has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Iron Deficiency

Drugs mentioned

• Ferric carboxymaltose (ferric carboxymaltose)

Snippet

Sponsor: Vifor (International) Inc. | Conditions: Iron Deficiency, Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2021-06-18